PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Update

PMGC Holdings Inc. (NASDAQ:ELAB) saw a significant drop in short interest in February. As of February 27th, there was short interest totaling 86,753 shares, a drop of 33.0% from the February 12th total of 129,521 shares. Approximately 2.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,370,775 shares, the short-interest ratio is presently 0.1 days. Based on an average daily trading volume, of 1,370,775 shares, the short-interest ratio is presently 0.1 days. Approximately 2.7% of the shares of the stock are sold short.

PMGC Trading Up 4.1%

Shares of ELAB stock traded up $0.18 during trading hours on Friday, hitting $4.58. 57,294 shares of the company were exchanged, compared to its average volume of 154,341. The firm has a fifty day moving average of $14.65 and a 200 day moving average of $81.46. PMGC has a 1 year low of $3.97 and a 1 year high of $686.28.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, PMGC presently has an average rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.